- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2050-7771
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Nanobody-based CAR-T cells for cancer immunotherapy ; volume:10 ; number:1 ; day:25 ; month:4 ; year:2022 ; pages:1-18 ; date:12.2022
Biomarker Research ; 10, Heft 1 (25.4.2022), 1-18, 12.2022
- Urheber
-
Safarzadeh Kozani, Pouya
Naseri, Abdolhossein
Mirarefin, Seyed Mohamad Javad
Salem, Faeze
Nikbakht, Mojtaba
Evazi Bakhshi, Sahar
Safarzadeh Kozani, Pooria
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40364-022-00371-7
- URN
-
urn:nbn:de:101:1-2022070719291861470888
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Safarzadeh Kozani, Pouya
- Naseri, Abdolhossein
- Mirarefin, Seyed Mohamad Javad
- Salem, Faeze
- Nikbakht, Mojtaba
- Evazi Bakhshi, Sahar
- Safarzadeh Kozani, Pooria
- SpringerLink (Online service)
Ähnliche Objekte (12)
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Development of nanobodies targeting hepatocellular carcinoma and application of nanobody-based CAR-T technology
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours
Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7
Visualizing CAR-T cell Immunotherapy Using 3 Tesla Fluorine-19 MRI
Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy
Engineering CAR-T cells
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Development of nanobodies targeting hepatocellular carcinoma and application of nanobody-based CAR-T technology
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours
Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7
Visualizing CAR-T cell Immunotherapy Using 3 Tesla Fluorine-19 MRI
Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy
Engineering CAR-T cells
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Development of nanobodies targeting hepatocellular carcinoma and application of nanobody-based CAR-T technology
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours
Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7
Visualizing CAR-T cell Immunotherapy Using 3 Tesla Fluorine-19 MRI
Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy